TH-302 in combination with doxorubicin for locally advanced or metastatic, unresectable soft tissue sarcoma â“ first line

Source:
Centre for Reviews and Dissemination Health Technology Assessments - CRD HTA
Publisher:
Centre for Reviews and Dissemination
Publication date:
23 February 2015

Abstract

This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database